Quick Answer
Veradermics, Inc reported Stockholders Equity of -$121.01 million for fiscal year 2025.
Veradermics, Inc Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$121.01M | -149.6% |
| 2024 | -$48.48M | -118.0% |
| 2023 | -$22.24M | — |
- Veradermics, Inc showed a decrease of -149.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2023–2025 period, Veradermics, Inc’s stockholders equity has declined by 444.1% (from -$22.24 million to -$121.01 million).
- The most recent figure is from Veradermics, Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: